The pro- and anti-tumor role of ILC2s

被引:22
|
作者
Trabanelli, Sara [1 ]
Chevalier, Mathieu F. [2 ,3 ,4 ]
Derre, Laurent [2 ]
Jandus, Camilla [1 ]
机构
[1] Univ Lausanne, UNIL CHUV, Dept Oncol, CH-1066 Epalinges, Switzerland
[2] Univ Hosp Lausanne CHUV, Urol Res Unit, CH-1011 Lausanne, Switzerland
[3] Hop St Louis, Lab Human Immunol Pathophysiol & Immunotherapy, INSERM U976, Paris, France
[4] Univ Paris, Hop St Louis, Inst Rech St Louis, Paris, France
基金
瑞士国家科学基金会;
关键词
Group-2 innate lymphoid cells; ILC2; Cancer; Tumor immunoregulation; INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR BCL11B; T-CELLS; TYPE-2; IMMUNITY; FACTOR GATA3; INFLAMMATION; EXPRESSION; GROWTH; IL-33; CARCINOGENESIS;
D O I
10.1016/j.smim.2019.04.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group 2 innate lymphoid cells (ILC2s) are critical for the initiation of type 2 inflammatory diseases. However, ILC2s are also involved in the establishment of the immune microenvironment during tumor development, growth and metastasization. In this context, ILC2s have been shown to be either tumor-suppressive or tumor-promoting according to the tumor type, the cytokine secreted and the other immune cells that are, in turn, recruited and/or activated.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Basophils balance ILC2s
    Bird, Lucy
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) : 592 - +
  • [22] ILC2s skew the fat
    Yvonne Bordon
    Nature Reviews Immunology, 2015, 15 (2) : 67 - 67
  • [23] Heterogeneity of ILC2s in the Lungs
    Asaoka, Masato
    Kabata, Hiroki
    Fukunaga, Koichi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Basophils balance ILC2s
    Lucy Bird
    Nature Reviews Immunology, 2020, 20 : 592 - 593
  • [25] Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors
    Zlobec, Inti
    Lugli, Alessandro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (47) : 5898 - 5906
  • [26] Invasive front of colorectal cancer:Dynamic interface of pro-/anti-tumor factors
    Inti Zlobec
    Alessandro Lugli
    World Journal of Gastroenterology, 2009, 15 (47) : 5898 - 5906
  • [27] Magnesium as a Co-Factor: A Vital Cation with Pro- and Anti-Tumor Effects
    Dharshini, Muthu Krishnan Dhivya
    Prabhu, Dhamodharan
    Gopinath, Subash C. B.
    CURRENT CANCER DRUG TARGETS, 2025, 25 (02) : 103 - 107
  • [28] Current overview of the role of neuropeptides in ILC2s and future directions
    Irie, Misato
    Sasahara, Kotaro
    Artis, David
    Kabata, Hiroki
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (03) : 294 - 300
  • [29] Enabling anti-tumor immunity by unleashing ILC2
    Mattiola, Irene
    Diefenbach, Andreas
    CELL RESEARCH, 2020, 30 (06) : 461 - 462
  • [30] Enabling anti-tumor immunity by unleashing ILC2
    Irene Mattiola
    Andreas Diefenbach
    Cell Research, 2020, 30 : 461 - 462